Johnson and Johnson Newswire

Johnson and Johnson Newswire

Comprehensive Real-Time News Feed for Johnson and Johnson.

Results 1 - 20 of 1,917 in Johnson and Johnson

  1. No Innovator Liability: National Drug Code Saves the DayRead the original story w/Photo

    22 hrs ago | JD Supra

    This is a quick-hit post as we head into the Independence Day holiday weekend. The Southern District of West Virginia's order this week in McNair v.

    Comment?

  2. Preclinical trial data brings new hope for HIV vaccineRead the original story w/Photo

    Yesterday | Medical News Today

    Publishing data from preclinical trials in nonhuman primates in the journal Science , Crucell Holland B.V, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, reveal encouraging results for their HIV vaccine. "Our ultimate goal is to develop a vaccine that prevents HIV in the first place," says Dr. Paul Stoffels of Johnson & Johnson.

    Comment?

  3. Exclusive: Hospira Wins French Biosimilar Drug Tender At 45 Percent DiscountRead the original story w/Photo

    Yesterday | Medical Daily

    A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis, Crohn's disease and psoriasis in a victory for a new type of medicine known as biosimilars. In a document seen by Reuters, the central purchasing agency for the Assistance Publique - HA pitaux de Paris said on Friday it had decided to buy the biosimilar version of infliximab from Hospira, after the company offered a discount of some 45 percent to branded Remicade.

    Comment?

  4. New CEO to Lead the Alzheimer Society Against the Dementia ChallengeRead the original story w/Photo

    Yesterday | PRWeb

    Dementia is becoming a critical issue as Ontario's population ages. In less than five years, 250,000 Ontarians will be living with this disease.

    Comment?

  5. Scanning The SA Family For Alpha: RosenoseRead the original story w/Photo

    Yesterday | Seeking Alpha

    The interaction between readers is perhaps the most important component of subscribing to Seeking Alpha and participating in the areas of choice. If there is anything about Seeking Alpha that ties all of us together, it is the elusive goal of finding "alpha."

    Comment?

  6. Grant creates jobs for teensRead the original story w/Photo

    Yesterday | Lowell Sun

    The City of Lowell's Recreation Department will be hiring four teen-age workers for this summer after Attorney General Maura Healey announced Wednesday that more than $300,000 in grants will fund nearly 200 summer jobs for 46 organizations across the state. Lowell's Recreation Department was selected for the Summer Youth Jobs Grant Program among a competitive pool of applicants, according to the Attorney General's website.

    Comment?

  7. Now wheelchair that can climb stairsRead the original story w/Photo

    Yesterday | The Indian Express

    Back in 2003, a stair-climbing wheelchair called iBOT was launched by Johnson & Johnson. It was revolutionary and touched the lives of the wheelchair-bound who could enjoy their much-needed freedom.

    Comment?

  8. Vaccine Combo Demonstrates Protection Against HIV-like Virus in Monkey StudyRead the original story w/Photo

    Yesterday | HIV and Hepatitis

    Administering a 2-part prime-boost vaccine prevented infection in half of a dozen rhesus monkeys repeatedly exposed to simian immunodeficiency virus , and antibody responses against viral envelope proteins appeared to be the key to protection, according to a study published in the July 2 advance edition of Science magazine . Numerous studies over the course of the HIV/AIDS epidemic have evaluated a wide range of vaccine approaches, but most have produced disappointing results.

    Comment?

  9. Global Orthopedic Trauma Fixation Devices Market Will Hit $9.4...Read the original story

    Yesterday | PR.com

    The report segments the market under four geographies: North America, Europe, Asia Pacific and Rest of the World . The report provides the market size and forecast for the different segments under these geographies for the period of 2009 to 2020.

    Comment?

  10. New experimental HIV vaccine shows promiseRead the original story w/Photo

    Yesterday | India.com

    New York, July 3: A vaccine regimen that first primes the immune system and then boosts it to increase the response could ultimately prove to be the strategy for protecting against the global human immunodeficiency virus infection, new research suggests.The study showed that the investigational "prime-boost" vaccine regimen provided complete protection to non-human primates from becoming infected with simian immunodeficiency virus , a virus similar to HIV that infects the primates. These results have now encouraged scientists to study the efficacy of the vaccine on a human study that is currently enrolling 400 volunteers in the US and Rwanda, with sites in South Africa, Uganda and Thailand opening soon."

    Comment?

  11. Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile SiteRead the original story w/Photo

    Yesterday | PRWeb

    Attorneys handling national talcum powder lawsuits for ovarian cancer allegations launch a new mobile version of the Talcum Powder Cancer Lawsuit Center website, from the Onder Law Firm. Talcum powder attorneys representing clients in national lawsuits announce the launch of a new responsive website to replace their existing Talcum Powder Cancer Lawsuit Center website.

    Comment?

  12. Cook deluged by product lawsuitsRead the original story w/Photo

    Yesterday | Indianapolis Business News

    One of the immediate challenges for new Cook Group Inc. CEO Pete Yonkman is all too familiar: a pile of lawsuits from patients claiming one of Cook's medical devices harmed them.

    Comment?

  13. J&J vaccine completely prevented HIV in half of monkeys in trialRead the original story

    Thursday | WNFL-AM Green Bay

    An experimental Johnson & Johnson vaccine completely prevented HIV infection in half of monkeys that got the shot and then were exposed to high doses of an aggressive virus, results that spurred the company to test the vaccine in people, academic and company researchers said on Thursday. The international trial is underway in 400 healthy volunteers in the United States, East Africa, South Africa and Thailand.

    Comment?

  14. Pfizer bought RTP drug firm Icagen for $56M, sells it for $500K plus 'earn outs'Read the original story w/Photo

    Thursday | Local Tech Wire

    Icagen, a Triangle-based drug firm that had pursued cures for such diseases as sickle cell anemia and epilepsy, is relaunching as a services company after the assets of the firm that were sold to Pfizer in 2011 are acquired by XPro Sciences. XPro is paying Pfizer $500,000 up front for the Icagen name, technology and employees plus "earn outs" for as much as $10.5 million.

    Comment?

  15. J&J vaccine completely prevented HIV in half of monkeys in ...Read the original story w/Photo

    Thursday | AlertNet

    We use cookies to ensure that we give you the best experience on our website. By continuing to browse our site, you are giving your consent for us to set cookies.

    Comment?

  16. Investigational HIV vaccine regimen shows encouraging results in non-human primatesRead the original story w/Photo

    Thursday | PhysOrg Weblog

    Johnson & Johnson announced today that scientists at Beth Israel Deaconess Medical Center , Crucell Holland B.V, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and several other collaborators today published results from a preclinical study of an HIV vaccine regimen used in in non-human primates. The study, published in the online edition of Science , suggests that a "heterologous prime-boost" vaccine regimen-which first primes the immune system, then boosts the immune system to increase the response, could ultimately prove to be a strategy for protecting against global human immunodeficiency virus infection.

    Comment?

  17. Study shows novel HIV vaccine regimen provides robust protection in non-human primatesRead the original story w/Photo

    Wednesday | EurekAlert!

    A new study led by scientists at Beth Israel Deaconess Medical Center shows that an HIV-1 vaccine regimen, involving a viral vector boosted with a purified envelope protein, provided complete protection in half of the vaccinated non-human primates against a series of six repeated challenges with simian immunodeficiency virus , a virus similar to HIV that infects NHPs. These findings are published online today in Science .

    Comment?

  18. Women have reported "serious and debilitating problems" following ...Read the original story w/Photo

    Thursday | Ely Standard

    ... walls. Joseph Ogah, consultant gynaecologist, who the report says 'is sponsored to attend workshops by Johnson and Johnson', said: "We need to know more about what happens to women in the long term. This review found 35 trials carried out more than ...

    Comment?

  19. James G. Gayhardt, businessmanRead the original story w/Photo

    Thursday | The Baltimore Sun

    James G. Gayhardt, a retired partner in a Baltimore integrated security firm, died May 21 at Greater Baltimore Medical Center of heart failure. He was 83. The son of Francis Patrick Gayhardt, general manager of Bugle Linen Service, and Evelyn Cecilia Hines Gayhardt, a homemaker, James George Gayhardt was born in Baltimore and raised in Catonsville.

    Comment?

  20. Minister Hayes pleas for patience on Cashel jobsRead the original story w/Photo

    Feb 7, 2015 | Nationalist

    Congratulations, you're now registered! Let us know what news and updates you want to hear about and we'll send them straight to your inbox. Minister Hayes was responding to concerns raised by public representatives this week regarding the lack of progress since it was announced in February that the plant had been purchased by a company in Singapore.

    Comment?